Mitoguazone
Mitoguazone (Methylglyoxal-bis (guanylhydrazone) ) is a synthetic polycarbonyl derivative with potent antineoplastic activity. Mitoguazone is a brain-penetrant and competitive S-adenosyl-methionine decarboxylase (SAMDC) inhibitor that disrupts polyamine biosynthesis. Mitoguazone induces cell apoptosis. Mitoguazone inhibits HIV DNA integration into the cellular DNA in both monocytes and macrophages. Mitoguazone has the potential for acute leukemia, Hodgkin's and non-Hodgkin's lymphoma treatment.
Product Specifications
CAS Number
459-86-9
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
In Vitro: H2O : 50 mg/mL (271.44 mM; ultrasonic and adjust pH to 9 with HCl) DMSO : 8.33 mg/mL (45.22 mM; Ultrasonic (<60°C)
Smiles
C\C (\C=N\NC (N) =N) =N/NC (N) =N
Molecular Formula
C5H12N8
Molecular Weight
184.2
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
Unrip Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Recombinant Staphylococcus aureus ATP synthase subunit c (atpE)
Recombinant Staphylococcus aureus ATP synthase subunit c (atpE)
Recombinant Staphylococcus aureus ATP synthase subunit c (atpE)